Perrigo Company plc Ordinary Shares (PRGO): Price and Financial Metrics

Perrigo Company plc Ordinary Shares (PRGO): $41.62

0.45 (+1.09%)

POWR Rating

Component Grades













PRGO Stock Summary

  • PERRIGO Co plc's stock had its IPO on December 17, 1991, making it an older stock than 82.28% of US equities in our set.
  • In terms of twelve month growth in earnings before interest and taxes, PERRIGO Co plc is reporting a growth rate of -106.22%; that's higher than merely 18.09% of US stocks.
  • The volatility of PERRIGO Co plc's share price is greater than that of merely 17.98% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to PRGO, based on their financial statements, market capitalization, and price volatility, are LNDC, AIMC, CBT, VISL, and ACOR.
  • PRGO's SEC filings can be seen here. And to visit PERRIGO Co plc's official web site, go to

PRGO Stock Price Chart Interactive Chart >

Price chart for PRGO

PRGO Price/Volume Stats

Current price $41.62 52-week high $58.83
Prev. close $41.17 52-week low $38.20
Day low $41.09 Volume 912,100
Day high $41.67 Avg. volume 1,373,115
50-day MA $41.90 Dividend yield 2.31%
200-day MA $46.91 Market Cap 5.56B

Perrigo Company plc Ordinary Shares (PRGO) Company Bio

Perrigo Company develops, manufactures, and distributes generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. The company was founded in 1887 and is based in Dublin, Ireland.

PRGO Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$41.62$5.98 -85%

Below please find a table outlining a discounted cash flow forecast for PRGO, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that PERRIGO Co plc ranked in the 17th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of PERRIGO Co plc, consider:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 61. Notably, its equity weight is greater than merely 16.23% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Its compound free cash flow growth rate, as measured over the past 5.55 years, is -0.14% -- higher than merely 11.3% of stocks in our DCF forecasting set.
  • PERRIGO Co plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as PRGO, try ZBH, BHC, IIN, LCI, and MD.

PRGO Latest News Stream

Event/Time News Detail
Loading, please wait...

PRGO Latest Social Stream

Loading social stream, please wait...

View Full PRGO Social Stream

Latest PRGO News From Around the Web

Below are the latest news stories about PERRIGO Co plc that investors may wish to consider to help them evaluate PRGO as an investment opportunity.

Is PRGO Stock A Buy or Sell?

In this article we will take a look at whether hedge funds think Perrigo Co Plc (NASDAQ:PRGO) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips […]

Yahoo | April 14, 2021

Top Insider Buys Highlight for the Week of March 26

The largest Insider Buys this week were for Perrigo Co. PLC, PennyMac Financial Services Inc., Biohaven Pharmaceutical Holding Co. Ltd. and Olo Inc.

Yahoo | March 28, 2021

Perrigo Company plc's (NYSE:PRGO) Intrinsic Value Is Potentially 54% Above Its Share Price

In this article we are going to estimate the intrinsic value of Perrigo Company plc ( NYSE:PRGO ) by estimating the...

Yahoo | March 4, 2021

Clarityne Market 2021 Business Development, Size, Share, Analysis And Opportunities To 2028 | Bayer AG, Perrigo company plc., Sun Pharmaceutical Industries Ltd., Apotex Inc, Pfizer Inc., Sandoz International

Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Clarityne Market: Global Opportunity Analysis and Industry Forecast 2021-2028’. The Clarityne Market is expected to witness growth in upcoming years due to factors such as increase in target patient population, which

OpenPR | March 3, 2021

Perrigo Company PLC (PRGO) Q4 2020 Earnings Call

Perrigo Company PLC (NYSE: PRGO) Q4 2020 earnings call dated Mar. 01, 2021 Corporate Participants: Bradley Joseph — Vice President, Global Investor Relations & Corporate Communications Murray S. Kessler — President & Chief Executive Officer […] The post Perrigo Company PLC (PRGO) Q4 2020 Earnings Call first appeared on AlphaStreet .

AlphaStreet | March 2, 2021

Read More 'PRGO' Stories Here

PRGO Price Returns

1-mo -2.42%
3-mo -3.70%
6-mo -6.23%
1-year -18.24%
3-year -46.45%
5-year -65.53%
YTD -6.39%
2020 -11.97%
2019 35.65%
2018 -55.08%
2017 5.58%
2016 -42.14%

PRGO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PRGO Dividend History

Continue Researching PRGO

Here are a few links from around the web to help you further your research on PERRIGO Co plc's stock as an investment opportunity:

PERRIGO Co plc (PRGO) Stock Price | Nasdaq
PERRIGO Co plc (PRGO) Stock Quote, History and News - Yahoo Finance
PERRIGO Co plc (PRGO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0397 seconds.